USPTO Launches Streamlined Claim Set Pilot To Accelerate Patent Examination

Key Takeaways:

• The U.S. Patent and Trademark Office (USPTO) introduced a new pilot program offering expedited examination for certain pending, unexamined applications with narrowly tailored claim sets.
• The program imposes strict eligibility and claim requirements but may reduce pendency, especially relevant for biotech and life sciences applicants facing long examination timelines.
• Biotech and life sciences companies should review the application criteria and downstream restrictions carefully before opting in — particularly if pursuing broader patent protection or follow-on filings.

A series of procedural changes at the USPTO is influencing the strategy for biotech and life sciences applicants. Over the past year, the agency introduced two new fees and launched a streamlined examination pilot, each with implications for how and when applications are filed. This alert focuses on the new Streamlined Claim Set Pilot Program, which aims to reduce pendency